Mesa Laboratories Inc (OQ:MLAB)

Business Focus: Medical Equipment, Supplies & Distribution

Sector:  Healthcare Industry:  Medical Equipment, Supplies & Distribution
 
See Regulatory Filings on SEC
Company Contact
Address: 12100 W 6th Ave
LAKEWOOD 80228-1252
Tel: N/A
Website: https://mesalabs.com
IR: See website
<
Key People
Gary M. Owens
President, Chief Executive Officer, Director
John V. Sakys
Chief Financial Officer, Vice President
Brian Archbold
Senior Vice President - Continuous Improvement
Business Overview
Mesa Laboratories, Inc. is a multinational manufacturer, developer, and seller of life sciences tools and critical quality control solutions. Its segments include Clinical Genomics, Sterilization and Disinfection Control, Biopharmaceutical Development, and Calibration Solutions. Its Clinical Genomics segment develops, manufactures, and sells throughput genetic analysis tools used by labs to perform clinical genomic testing in several therapeutic areas. Its Sterilization and Disinfection Control segment manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization and disinfection processes. Biopharmaceutical Development segment develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. Its Calibration Solutions segment develops, manufactures, and sells quality control products used to measure or calibrate temperature, pressure, pH, humidity, and other such parameters.
Financial Overview
For the nine months ended 31 December 2023, Mesa Laboratories Inc revenues decreased 4% to $157.3M. Net income increased 6% to $337K. Revenues reflect Clinical Genomics segment decrease of 15% to $41.5M, Biopharmaceutical Development segment decrease of 18% to $28.5M, United States segment decrease of 11% to $79.2M, China segment decrease of less than 1% to $18.6M.
Employees: 698 as of Mar 31, 2023
Reporting Currency: U.S. Dollars
Enterprise value: $830.67M as of Dec 31, 2023
Annual revenue (TTM): $212.87M as of Dec 31, 2023
EBITDA (TTM): $35.69M as of Dec 31, 2023
Net annual income (TTM): $0.95M as of Dec 31, 2023
Free cash flow (TTM): $37.27M as of Dec 31, 2023
Net Debt Last Fiscal Year: $204.74M as of Dec 31, 2023
Shares outstanding: 5,394,051 as of Jan 29, 2024
Index Membership: S&P 600 Small Cap
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.